Schering NV
Schering NV, a prominent player in the pharmaceutical industry, is headquartered in Belgium (BE) and operates extensively across Europe and North America. Founded in the late 19th century, the company has a rich history marked by significant milestones in drug development and innovation.
Specialising in prescription medicines, Schering NV focuses on areas such as oncology, immunology, and gynaecology, offering unique products that address unmet medical needs. Their commitment to research and development has positioned them as a leader in the biopharmaceutical sector, with notable achievements in advancing therapies that improve patient outcomes.
With a strong market presence, Schering NV continues to drive progress in healthcare, leveraging cutting-edge technology and scientific expertise to deliver high-quality solutions that enhance the quality of life for patients worldwide.
+51 vs industry average
Schering NV’s score of 89 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Schering NV?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Schering NV yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Schering NV’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Schering NV yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Bayer Aktiengesellschaft
Carbon Disclosure Project
Inherited from Bayer AktiengesellschaftThe Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Bayer AktiengesellschaftRE 100
Climate Action 100
Inherited from Bayer AktiengesellschaftEmissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project